Skip to main content

What the FDA labels say about taking them together

Dronedarone and propranolol

Dronedarone's FDA label of May 29, 2025 names propranolol in its drug interactions section; the propranolol labels PlainMeds reads (4) do not name dronedarone. The dronedarone label: “Beta-Blockers and Other CYP2D6 Substrates Dronedarone increased the exposure of propranolol and metoprolol.”

Check it at the source: the dronedarone FDA label on DailyMed (effective May 29, 2025, Sanofi-Aventis U.S. LLC); the propranolol FDA label on DailyMed (effective January 15, 2026, Mylan Pharmaceuticals Inc.).

What does the dronedarone label say about propranolol?

Dronedarone label, drug interactions

Beta-Blockers and Other CYP2D6 Substrates Dronedarone increased the exposure of propranolol and metoprolol.

Source: FDA drug label (Multaq), Sanofi-Aventis U.S. LLC, effective May 29, 2025 (SPL set 7fa41601-7fb5-4155-8e50-2ae903f0d2d6), via openFDA; the full label on DailyMed

What does the propranolol label say about dronedarone?

Propranolol's label (effective January 15, 2026) and its 3 other brand-application labels do not name dronedarone in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Propranolol Hydrochloride), Mylan Pharmaceuticals Inc., effective January 15, 2026 (SPL set b94dcec7-7633-4a33-9cea-48161adeaf93), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

0Dronedarone generic labelers
42Propranolol generic labelers
DronedaronePropranolol
Labeled forn/aHigh blood pressure, Angina, Atrial fibrillation, Migraine
Boxed warningYesNo
Pharmacy cost (NADAC)$13.19 per tablet 400 mg tablet$0.0493 per tablet 20 mg tablet
Shortage nowNo current entryIn shortage

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?